Projecting Parkinson’s disease burden
BMJ 2025; 388 doi: https://doi.org/10.1136/bmj.r350 (Published 05 March 2025) Cite this as: BMJ 2025;388:r350Linked Research
Projections for prevalence of Parkinson’s disease and its driving factors in 195 countries and territories to 2050: modelling study of Global Burden of Disease Study 2021
- Tobias Kurth, professor1,
- Ralph Brinks, professor2
- 1Institute of Public Health, Charité - Universitätsmedizin Berlin, Berlin, Germany
- 2Medical Biometry and Epidemiology, Faculty of Health/School of Medicine, Witten/Herdecke University, Witten, Germany
- Correspondence to: T Kurth tobias.kurth{at}charite.de
Parkinson’s disease is a considerable health problem owing to its high and rising global prevalence, its progressively degenerative nature, and its wide range of symptoms. In 2019 more than 8.5 million people worldwide were living with Parkinson’s disease, a number that has more than doubled in the past 25 years.1 Parkinson’s disease has a severe impact on individuals and their families, including social consequences and economic costs.2 Tackling this complex disease requires a multifactorial approach including increased awareness, improved diagnostics, better treatments, and ongoing research to find a cure.
Projecting the future number of people with Parkinson’s disease is important for several reasons. Accurate projections enable appropriate allocation of healthcare resources and a better understanding of demand for specialists, drug treatments, rehabilitation, and long term care, preventing shortages that could lead to delayed diagnoses, inadequate treatment choices, and diminished health related quality of life for patients. Projections also inform targeted interventions, early diagnosis efforts, and public health prevention and management strategies. Understanding the growing prevalence of Parkinson’s disease underscores the need for continued research into its causes, treatments, and …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.